still suffer from nasal
blockage after sinus surgery?

if so, you may qualify for the RESOLVE II Study.

RESOLVE II is a study to determine whether an investigational, dissovable, steroid-releasing sinus product can improve chronic sinusitis symptoms in patients who had sinus surgery but continue to experience symptoms.


Caution: New Drug — Limited by Federal (or United States) law to investigational use.

© 2014 Intersect ENT, Inc. All rights reserved.   Home  |  Study Overview  |  Eligible Patients  |  Take the Next Step  |  FAQs

Intersect ENT is a registered trademark of Intersect ENT, Inc.

P500-1113 CLM-00001 Rev 1.0